The CFO of Amphastar Pharmaceuticals sold 28,631 shares for $814,669, according to a recent SEC filing.

Nov 7, 2026, 10:02 AM ETPaperworkRead the original at moomoo.com

Neutral

Amphastar reported its CFO's sale of 28,631 shares for $814,669. He had set the trading plan in March, and the filing reports no change to the company's business.

AMPH · Amphastar Pharmaceuticals

AI read · Neutral

The AI's read

The plan was set months before the sale, so it gives little reason to think the executive acted on a fresh change in Amphastar's prospects. The filing reports no new information about the company's products, sales, or profits.

Get alerts for AMPH

Follow Amphastar Pharmaceuticals (AMPH) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AMPH

Free on the App Store and Google Play, or on the web.